Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.
Oro-facial fibrosis in systemic sclerosis (Scleroderma;SSc) has a major impact on mouth function, facial appearance, and patient quality of life. Lipotransfer is a method of reconstruction that can be used in the treatment of oro-facial fibrosis. The effect of this treatment not only restores oro-fa...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0218068 |
| _version_ | 1819020778966876160 |
|---|---|
| author | Aurora Almadori Michelle Griffin Caroline M Ryan Debbie F Hunt Esther Hansen Ravi Kumar David J Abraham Christopher P Denton Peter E M Butler |
| author_facet | Aurora Almadori Michelle Griffin Caroline M Ryan Debbie F Hunt Esther Hansen Ravi Kumar David J Abraham Christopher P Denton Peter E M Butler |
| author_sort | Aurora Almadori |
| collection | DOAJ |
| description | Oro-facial fibrosis in systemic sclerosis (Scleroderma;SSc) has a major impact on mouth function, facial appearance, and patient quality of life. Lipotransfer is a method of reconstruction that can be used in the treatment of oro-facial fibrosis. The effect of this treatment not only restores oro-facial volume but has also been found to reverse the effects of oro-facial fibrosis. Adipose derived stem cells (ADSCs) within the engrafted adipose tissue have been shown to be anti-fibrotic in SSc and are proposed as the mechanism of the anti-fibrotic effect of lipotransfer. A cohort of 62 SSc patients with oro-facial fibrosis were assessed before and after stem cell enriched lipotransfer treatment. Clinical evaluation included assessment of mouth function using a validated assessment tool (Mouth Handicap in Systemic Sclerosis Scale-MHISS), validated psychological measurements and pre and post-operative volumetric assessment. In addition, to understand the mechanism by which the anti-fibrotic effect of ADSCs occur, SSc derived fibroblasts and ADSCs from this cohort of patients were co-cultured in direct and indirect culture systems and compared to monoculture controls. Cell viability, DNA content, protein secretion of known fibrotic mediators including growth factor- β1 (TGF β-1) and connective tissue growth factor (CTGF) using ELISA analysis and fibrosis gene expression using a fibrosis pathway specific qPCR array were evaluated. Mouth function (MHISS) was significantly improved (6.85±5.07) (p<0.0001) after treatment. All psychological measures were significantly improved: DAS 24 (12.1±9.5) (p<0.0001); HADS-anxiety (2.8±3.2) (p<0.0001), HADS-depression (2.0±3.1) (p<0.0001); BFNE (2.9 ± 4.3) (p<0.0001); VAS (3.56±4.1) (p<0.0001). Multiple treatments further improved mouth function (p<0.05), DAS (p<0.0001) and VAS (p = 0.01) scores. SSc fibroblast viability and proliferation was significantly reduced in co-culture compared to monoculture via a paracrine effect over 14 days (p < 0.0001). Protein secretion of transforming growth factor (TGF-β1) and connective tissue growth factor (CTGF) was significantly reduced in co-culture compared to monoculture (p < 0.0001). Multiple fibrosis associated genes were down regulated in SSc co-culture compared to monoculture after 14 days including Matrix metalloproteinase-8 (MMMP-8), Platelet derived growth factor-β (PDGF-β) and Integrin Subunit Beta 6 (ITG-β6). Autologous stem cell enriched lipotransfer significantly improved the effects of oro-facial fibrosis in SSc in this open cohort study. Lipotransfer may reduce dermal fibrosis through the suppression of fibroblast proliferation and key regulators of fibrogenesis including TG-β1 and CTGF. Our findings warrant further investigation in a randomised controlled trial. |
| first_indexed | 2024-12-21T03:56:37Z |
| format | Article |
| id | doaj.art-059e2f1b8a0848eab779be554c26641f |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T03:56:37Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-059e2f1b8a0848eab779be554c26641f2022-12-21T19:16:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-01147e021806810.1371/journal.pone.0218068Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis.Aurora AlmadoriMichelle GriffinCaroline M RyanDebbie F HuntEsther HansenRavi KumarDavid J AbrahamChristopher P DentonPeter E M ButlerOro-facial fibrosis in systemic sclerosis (Scleroderma;SSc) has a major impact on mouth function, facial appearance, and patient quality of life. Lipotransfer is a method of reconstruction that can be used in the treatment of oro-facial fibrosis. The effect of this treatment not only restores oro-facial volume but has also been found to reverse the effects of oro-facial fibrosis. Adipose derived stem cells (ADSCs) within the engrafted adipose tissue have been shown to be anti-fibrotic in SSc and are proposed as the mechanism of the anti-fibrotic effect of lipotransfer. A cohort of 62 SSc patients with oro-facial fibrosis were assessed before and after stem cell enriched lipotransfer treatment. Clinical evaluation included assessment of mouth function using a validated assessment tool (Mouth Handicap in Systemic Sclerosis Scale-MHISS), validated psychological measurements and pre and post-operative volumetric assessment. In addition, to understand the mechanism by which the anti-fibrotic effect of ADSCs occur, SSc derived fibroblasts and ADSCs from this cohort of patients were co-cultured in direct and indirect culture systems and compared to monoculture controls. Cell viability, DNA content, protein secretion of known fibrotic mediators including growth factor- β1 (TGF β-1) and connective tissue growth factor (CTGF) using ELISA analysis and fibrosis gene expression using a fibrosis pathway specific qPCR array were evaluated. Mouth function (MHISS) was significantly improved (6.85±5.07) (p<0.0001) after treatment. All psychological measures were significantly improved: DAS 24 (12.1±9.5) (p<0.0001); HADS-anxiety (2.8±3.2) (p<0.0001), HADS-depression (2.0±3.1) (p<0.0001); BFNE (2.9 ± 4.3) (p<0.0001); VAS (3.56±4.1) (p<0.0001). Multiple treatments further improved mouth function (p<0.05), DAS (p<0.0001) and VAS (p = 0.01) scores. SSc fibroblast viability and proliferation was significantly reduced in co-culture compared to monoculture via a paracrine effect over 14 days (p < 0.0001). Protein secretion of transforming growth factor (TGF-β1) and connective tissue growth factor (CTGF) was significantly reduced in co-culture compared to monoculture (p < 0.0001). Multiple fibrosis associated genes were down regulated in SSc co-culture compared to monoculture after 14 days including Matrix metalloproteinase-8 (MMMP-8), Platelet derived growth factor-β (PDGF-β) and Integrin Subunit Beta 6 (ITG-β6). Autologous stem cell enriched lipotransfer significantly improved the effects of oro-facial fibrosis in SSc in this open cohort study. Lipotransfer may reduce dermal fibrosis through the suppression of fibroblast proliferation and key regulators of fibrogenesis including TG-β1 and CTGF. Our findings warrant further investigation in a randomised controlled trial.https://doi.org/10.1371/journal.pone.0218068 |
| spellingShingle | Aurora Almadori Michelle Griffin Caroline M Ryan Debbie F Hunt Esther Hansen Ravi Kumar David J Abraham Christopher P Denton Peter E M Butler Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. PLoS ONE |
| title | Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. |
| title_full | Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. |
| title_fullStr | Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. |
| title_full_unstemmed | Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. |
| title_short | Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. |
| title_sort | stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis |
| url | https://doi.org/10.1371/journal.pone.0218068 |
| work_keys_str_mv | AT auroraalmadori stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT michellegriffin stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT carolinemryan stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT debbiefhunt stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT estherhansen stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT ravikumar stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT davidjabraham stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT christopherpdenton stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis AT peterembutler stemcellenrichedlipotransferreversestheeffectsoffibrosisinsystemicsclerosis |